Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Divergent effects of lipids on stroke

A large study provides causal evidence of the opposing effects of plasma low-density lipoprotein (LDL) levels on ischemic and hemorrhagic stroke in a Chinese population and suggests there is a a net benefit associated with LDL lowering.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: The link between plasma LDL and stroke.


  1. 1.

    Feigin, V. L. et al. N. Engl. J. Med. 379, 2429–2437 (2018).

    Article  Google Scholar 

  2. 2.

    Sun, L et al. Nat. Med. (2019).

  3. 3.

    Di Angelantonio, E. et al. JAMA 302, 1993–2000 (2009).

    CAS  Article  Google Scholar 

  4. 4.

    Fulcher, J. et al. Lancet 385, 1397–1405 (2015).

    Article  Google Scholar 

  5. 5.

    Karatasakis, A. et al. J. Am. Heart Assoc. 6, e006910 (2017).

    Article  Google Scholar 

  6. 6.

    Hindy, G. et al. Stroke 49, 820–827 (2018).

    CAS  Article  Google Scholar 

  7. 7.

    Wang, X., Dong, Y., Qi, X., Huang, C. & Hou, L. Stroke 44, 1833–1839 (2013).

    CAS  Article  Google Scholar 

  8. 8.

    Baigent, C. et al. Lancet 376, 1670–1681 (2010).

    CAS  Article  Google Scholar 

  9. 9.

    Amarenco, P. et al. N. Engl. J. Med. 355, 549–559 (2006).

    CAS  Article  Google Scholar 

  10. 10.

    Elkind, M. S. et al. Cerebrovasc. Dis. 28, 266–275 (2009).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Mitchell S. V. Elkind.

Ethics declarations

Competing interests

M.S.V.E. discloses receiving personal compensation for serving as an expert witness for Merck/Organon and Auxilium; honoraria for writing chapters on stroke for UpToDate; and research support but no personal compensation for a federally funded clinical trial related to stroke prevention from both the BMS-Pfizer Alliance for Eliquis and Roche; and serving as an unpaid national board member of the American Heart Association. N.S.P. has no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Parikh, N.S., Elkind, M.S.V. Divergent effects of lipids on stroke. Nat Med 25, 543–544 (2019).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing